16729-019 : Mycophenolate Mofetil 500 mg Oral Tablet


NDC16729-019
Labeler: Accord Healthcare Inc.
Product Type: Human Prescription Drug
Drug Name: Mycophenolate Mofetil
Dosage Form: Oral Tablet
Application #: ANDA065416
Rev. Date: 


Appearance:


Markings: AHI;500
Shapes:  Oval
Colors:  Purple
Size (mm): 18
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

AHI 500: (16729-019) Mycophenolate Mofetil 500 mg Oral Tablet by Accord Healthcare Inc.
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 16729-019-01: 100 TABLET IN 1 BOTTLE (16729‑019‑01)
  • 16729-019-16: 500 TABLET IN 1 BOTTLE (16729‑019‑16)

Active Ingredients:

  • Mycophenolate Mofetil

Dosage Strength:

  • 500 mg

Inactive Ingredients:

  • Croscarmellose Sodium
  • Magnesium Stearate
  • Povidone K90
  • Cellulose, Microcrystalline
  • Hydroxypropyl Cellulose
  • Talc
  • Fd&c Blue No. 2
  • Ferrosoferric Oxide
  • Ferric Oxide Red
  • Polyethylene Glycol 400
  • Titanium Dioxide
  • Hypromelloses

Pharmaceutical Classes:

  • Antimetabolite Immunosuppressant [EPC]

Related Products:

Based on records with the same trade name.
  • 16729-094 Mycophenolate Mofetil 250 mg Oral Capsule by Accord Healthcare Inc.
  • 0054-0163 Mycophenolate Mofetil 250 mg Oral Capsule by Roxane Laboratories, Inc
  • 0054-0166 Mycophenolate Mofetil 500 mg Oral Tablet by Roxane Laboratories, Inc
  • 0093-7334 Mycophenolate Mofetil 250 mg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7477 Mycophenolate Mofetil 500 mg Oral Tablet by Teva Pharmaceuticals USA Inc
  • 0378-2250 Mycophenolate Mofetil 250 mg Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-4472 Mycophenolate Mofetil 500 mg Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0781-2067 Mycophenolate Mofetil 250 mg Oral Capsule by Sandoz Inc
  • 0781-5175 Mycophenolate Mofetil 500 mg Oral Tablet by Sandoz Inc
  • 17478-422 Mycophenolate Mofetil 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Akorn, Inc.
  • 17478-957 Mycophenolate Mofetil 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Akorn, Inc.
  • 42023-172 Mycophenolate Mofetil 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Par Pharmaceutical, Inc.
  • 42658-101 Mycophenolate Mofetil 500 mg Oral Tablet, Film Coated by Hisun Pharmaceuticals USA, Inc.
  • 42658-501 Mycophenolate Mofetil 250 mg Oral Capsule by Hisun Pharmaceuticals USA, Inc.
  • 50090-2246 Mycophenolate Mofetil 500 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 50090-2541 Mycophenolate Mofetil 500 mg Oral Tablet by A-s Medication Solutions
  • 50090-4275 Mycophenolate Mofetil 500 mg Oral Tablet, Film Coated by A-s Medication Solutions
  • 50268-581 Mycophenolate Mofetil 500 mg Oral Tablet, Film Coated by Avpak
  • 51079-379 Mycophenolate Mofetil 500 mg Oral Tablet by Udl Laboratories, Inc.
  • 51079-721 Mycophenolate Mofetil 250 mg Oral Capsule by Udl Laboratories, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16729-019 QR Code

< Prev: 16729-011Next: 16729-020 >

Related Discussions:

mycophenolate
is it for depression?...




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 January 2017.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA